These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2789075)

  • 1. Complete recovery of marrow function after treatment with anti-lymphocyte globulin is associated with high, whereas early failure and development of paroxysmal nocturnal haemoglobinuria are associated with low endogenous G-CSA-release.
    Nissen C; Moser Y; dalle Carbonare V; Gratwohl A; Speck B
    Br J Haematol; 1989 Aug; 72(4):573-7. PubMed ID: 2789075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antilymphocyte globulin (ALG) on bone marrow T/non-T cells from aplastic anaemia patients and normal controls.
    Tong J; Bacigalupo A; Piaggio G; Figari O; Marmont A
    Br J Haematol; 1989 Dec; 73(4):546-50. PubMed ID: 2692693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression.
    Nissen C; Tichelli A; Gratwohl A; Warthmann C; Moser Y; dalle Carbonare V; Sendelov S; Chklovskaia E; Jansen W; Wodnar-Filipowicz A; Sadallah S; Speck B
    Acta Haematol; 1999; 101(4):165-72. PubMed ID: 10436296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late haematological complications in severe aplastic anaemia.
    Tichelli A; Gratwohl A; Würsch A; Nissen C; Speck B
    Br J Haematol; 1988 Jul; 69(3):413-8. PubMed ID: 3044440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
    Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
    Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
    Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
    Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-lymphocyte globulin therapy in acquired aplastic anaemia.
    Agarwal MB; Agarwal UM; Bhave AB; Vishwanathan C
    J Assoc Physicians India; 1993 Jun; 41(6):371-3. PubMed ID: 8005976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin: colony-stimulating activity and lymphokine production.
    Tong J; Bacigalupo A; Piaggio G; Figari O; Sogno G; Marmont A
    Exp Hematol; 1991 Jun; 19(5):312-6. PubMed ID: 1902792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained trilineage response in a patient with ALG-resistant severe aplastic anaemia after treatment with G-CSF, erythropoietin and cyclosporin A: association of recovery with marked elevation of serum alkaline phosphatase.
    Weide R; Lyttelton M; Samson D; Görg C; Köppler H; Pflüger KH; Havemann K
    Br J Haematol; 1993 Nov; 85(3):608-10. PubMed ID: 7510993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia.
    Nissen C; Gratwohl A; Tichelli A; Stebler C; Würsch A; Moser Y; Dalle Carbonare V; Signer E; Buser M; Ritz R
    Br J Haematol; 1993 Feb; 83(2):319-25. PubMed ID: 7681318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
    Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
    Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
    Sun YX; Zhu MQ; He GS; Wang XL; Fang BZ; Lu C; Liu ZZ; Wu Q; Yang Y; Wu DP; Sun AN
    Zhonghua Nei Ke Za Zhi; 2013 Jul; 52(7):585-9. PubMed ID: 24267002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
    Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
    Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antilymphocyte globulin on granulocyte precursors in aplastic anaemia.
    Faille A; Barrett AJ; Balitrand N; Ketels F; Gluckman E; Najean Y
    Br J Haematol; 1979 Jul; 42(3):371-80. PubMed ID: 475996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
    Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
    Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-thymocyte globulin treatment of marrow aplasia associated with paroxysmal nocturnal haemoglobinuria (PNH) resulted in haematological improvement due to an expansion of the PNH clone.
    Cheung WC; Lam CC; Kwong YL
    Br J Haematol; 2003 Jan; 120(2):325-8. PubMed ID: 12542494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.